Zhaofei Zhou
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2-Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 04, 2026
Tumor mutation burden determined by a 645-cancer gene panel and compared with microsatellite instability and mismatch repair genes in colorectal cancer.
Journal: Journal of gastrointestinal oncology
Published: July 30, 2021
Author Correction: Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
Journal: Scientific reports
Published: October 15, 2020
A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Journal: Cancer management and research
Published: June 22, 2020
Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.
Journal: Cancer management and research
Published: December 22, 2019
Exon Coverage Variations Between Cancer Tissues and Adjacent Non-Cancerous Tissues are Prognostic Factors in Gastric Cancer.
Journal: OncoTargets and therapy
Published: October 11, 2019
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
Journal: Scientific reports
Published: September 09, 2019
Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis.
Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis.
Journal: Oncology letters
Published: January 08, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026